key: cord-0808880-rh3quul8 authors: Coelingh Bennink, Herjan J.T.; Foidart, Jean-Michel; Debruyne, Frans M.J. title: Treatment of Serious COVID-19 with Testosterone Suppression and High-dose Estrogen Therapy date: 2021-07-06 journal: Eur Urol DOI: 10.1016/j.eururo.2021.06.024 sha: 3e8f6e7dedbba8977a2e4f649f1b6e334fbb178f doc_id: 808880 cord_uid: rh3quul8 nan Reference: EURURO 9451 To appear in: European Urology Please cite this article as: { doi: https://doi.org/ This is a PDF file of an article that has undergone enhancements after acceptance, such as the addition of a cover page and metadata, and formatting for readability, but it is not yet the definitive version of record. This version will undergo additional copyediting, typesetting and review before it is published in its final form, but we are providing this version to give early visibility of the article. Please note that, during the production process, errors may be discovered which could affect the content, and all legal disclaimers that apply to the journal pertain. In comparison to females, males more frequently experience severe acute respiratory syndrome (SARS) caused by SARS-CoV-2 and also die more frequently from COVID-19, especially for the cohort older than 50 yr ( Fig. 1 ) [1] . At this age, the most important endocrine difference by sex is the 10-20-fold higher testosterone levels among males, ranging from 12 to 35 ng/ml, while levels among females range from 1 to 3 ng/ml. Estrogen levels do not differ between men and women after the age of 50 yr. Testosterone has inhibitory effects on the immune system in terms of both cytokine production and lymphocyte proliferation. Apart from these general effects, there are two specific testosterone-dependent host cellular proteins related to viral cell entry and to serious COVID-19 disease. First, the SARS-CoV-2 virus uses ACE2 to enter the host cell. Second, the viral spike protein is primed by TMPRSS2, which is an androgen-regulated protease, and inhibition of TMPRSS2 using a protease inhibitor blocks viral cell entry. Serious COVID-19 is characterized by deterioration of lung function, and testosterone-stimulated TMPRSS2 expression in the lung may explain the greater susceptibility to serious COVID-19 lung infections among men [2] . Suppression of ACE2 and TMPRSS2 by inhibition of testosterone synthesis may be an effective treatment for COVID-19, by interfering with viral cell entry or On the basis of these data, we propose to investigate the efficacy of ADT and high-dose estrogen (ADET) for the treatment of serious COVID-19 disease. We recently investigated this combination therapy for the treatment of advanced castration-sensitive prostate cancer, and observed strong antitestosterone and positive estrogenic effects [5] . The proposed ADET combined treatment will use gonadotropin-releasing hormone (GnRH) antagonists rather than luteinising hormone-releasing hormone agonists to avoid the initial testosterone increase that occurs with the latter [5] . To test the ADET hypothesis, we propose a clinical study in male and female patients admitted to an intensive care unit (ICU) because of SARS-CoV-2 infection. Patients would be randomized to no additional treatment or combined treatment with the GnRH antagonist degarelix and transdermal estradiol patches. All patients in the study would receive anticoagulant treatment. The primary endpoints would be death and duration of ICU stay. Global Health 50/50. The COVID-19 sex-disaggregated data tracker The double edge sword of testosterone's role in the COVID-19 pandemic Androgen-deprivation therapies for prostate cancer and risk of infection by SARS-CoV-2: a population-based study (N = 4532) Mortality in COVID-19 amongst women on hormone replacement therapy or combined oral contraception: a cohort study Estetrol cotreatment of androgen deprivation therapy in infiltrating or metastatic, castration-sensitive prostate cancer: a randomized, double-blind, phase II trial (PCombi) 1 -Incidence of male and female deaths per 100 000 population by age group in years reported in England during the period The authors wish to thank Jan Egberts (Terminal 4 Communications, Hilversum, The Netherlands) for providing manuscript preparation support.